Akademik Veri Yönetim Sistemi
12th International Hippocrates Congress on Medical and Health Sciences, Ankara, Türkiye, 1 - 03 Eylül 2023, ss.148-149, (Özet Bildiri)
Objecitive: Smoking is sometimes a single trigger factor for acute myocardial infarction (AMI), especially in the young and middle-aged population. Although the frequency of smoking cessation after AMI varies greatly between studies, the rate of relapse in patients who quit smoking is quite high. The aim of this study was to evaluate the prevalence and predictors of relapse of smoking in patients who quit smoking after AMI. Metod: Our study is a retrospective, observational study. The data of the patients who quit smoking in the first week after AMI in the cardiology outpatient clinic of our hospital were examined in the hospital registry system.The smoking status of these patients at 1-year controls was evaluated. At the end of 1 year, patients who did not smoke and those who started smoking again were compared. Results: A total of 1335 patients were included in the study. t was observed that 59.6% (n=739) of the patients started smoking again. Baseline demographic characteristics of the relapsed and non-relapsed groups are shown in Table 1. Smoking relapsers consisted of younger and male patients (58.3±11.8vs63.2±12.4,p:0.027) (531(71.8%)vs311(52.2%),p:0.001).Relapse was more common in STEMI patients (389(52.7%) vs311(52.2%),p:<0.001). Relapse was significantly higher in patients with chronic obstructive pulmonary disease (COPD) (84(11.3%)vs43(7.3%),p:<0.001). Patients with EF >40% after acute MI and those using antidepressant drugs had a higher rate of relapse (431(58.3%) vs272(45.7%),p:0.007) (194(26.1%) vs124(20.8%),p:0.001). While there was no difference in the duration of smoking in both groups, relapses were higher as daily smoking increased. Conclusion: In our study, it was observed that young patients who use antidepressants, have chronic obstructive pulmonary disease and do not develop heart failure are at higher risk to start smoking again in the first year after AMI. We think that it is important to give closer follow-up and more intensive smoking cessation therapy especially to this patient group.